Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 1118 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
6 Мб
Скачать
201
experimental study //Digestive diseases and sciences. – 2002. – Vol. 47, №.
https://t.me/med1917
9. – P. 1953-1958.
128) Passot G., Chun Y.S., Kopetz S.E., Zorzi D., Brudvik K.W., Kim B.J.,
Conrad C., Aloia T.A., Vauthey J.N. Predictors of Safety and Efficacy of 2­Stage Hepatectomy for Bilateral Colorectal Liver Metastases. J Am Coll Surg. 2016; 18. pii: S1072-7515(16)00042-9
129) Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA.
Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg. 2007;11:860–868. doi: 10.1007/s11605-007-0149-4.
130) Petrowsky H., Breitenstein S., Slankamenac K. Effects of pentoxifylline
on liver regeneration. Ann. Surg. 2010;252:813–822.
131) Pichlmayr R, Grosse H, Hauss J, et al. Technique and preliminary results
of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver. Br J Surg 1990; 77 (1): 21–6.
132) Pietsch UC, Herrmann ML, Uhlmann D, Busch T, Hokema F, Kaisers
UX, et al. Blood lactate and pyruvate levels in the perioperative period of liver resection with Pringle manoeuvre. Clin Hemorheol Microcirc. 2010;44:269–281.
133) Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al. Improving
perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698–708
134) Pulitanò C, Aldrighetti L, Arru M, Finazzi R, Soldini L, Catena M, et al.
Prospective randomized study of the benefits of preoperative corticosteroid administration on hepatic ischaemia–reperfusion injury and cytokine response in patients undergoing hepatic resection. HPB. 2007;9:183–189.
135) Rahbari N.N., Garden O.J., Padbury R. Posthepatectomy liver failure: a
definition and grading by the international study group of liver surgery (ISGLS) Surgery (St Louis) 2011;149:713–724.
202
136) Rahman SH, Evans J, Toogood GJ, Lodge PA, Prasad KR. Prognostic
https://t.me/med1917
utility of postoperative C-reactive protein for post-hepatectomy liver failure. Arch Surg. 2008;143:247–253.
137) Raut V. et al. Review of the surgical approach to prevent small-for-size
syndrome in recipients after left lobe adult LDLT //Surgery today. – 2014. – Vol. 44, №. 7. – P. 1189-1196.
138) Reissfelder C, Rahbari NN, Koch M, Kofler B, Sutedja N, Elbers H, et
al. Postoperative course and clinical significance of biochemical blood tests following hepatic resection. Br J Surg. 2011;98:836–844.
139) Ren Y. S. et al. Benefcial effects of splenectomy on liver regeneration in
a rat model of massive hepatectomy //Hepatobiliary & Pancreatic Diseases International. – 2012. – Vol. 11, №. 1. – P. 60-65.
140) Ren Z., Xu Y., Zhu S. Indocyanine green retention test avoiding liver
failure after hepatectomy for hepatolithiasis. Hepato­Gastroenterology. 2012;59:782–784.
141) Ribero D., Chun Y.S., Vauthey J.N. Standardized liver volumetry for
portal vein embolization. Semin. Intervent. Radiol. 2008;25:104–109.
142) Robinson S.M., Wilson C.H., Burt A.D., Manas D.M., White S.A.
Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann. Surg Oncol. 2012;19:4287–4299.
143) Ronco C Bellomo R. Continuous renal replacement therapy in critically
ill patients. Nephrology Dialysis Transplantation . 2001;16:67–72.
144) Ryan C.J., Guest J., Harper A.M., Blumgart L.H. Liver blood flow
measurements in the portacavally transposed rat before and after partial hepatectomy. Br. J. Exp. Pathol. 1978;59:111–115.
145) Ryan P, Nanji S, Pollett A, et al. Chemotherapy-induced liver injury in
metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis
203
is associated with preoperative chemotherapy. Am J Surg
https://t.me/med1917
Pathol. 2010;34:784–791. doi: 10.1097/PAS.0b013e3181dc242c.
146) Sakamoto T., Liu Z., Murase N. Mitosis and apoptosis in the liver of
interleukin-6-deficient mice after partial hepatectomy. Hepatology. 1999;29:403–411.
147) Saner F. Kidney failure following liver resection. Transplant
Proc. 2008;40:1221–1224.
148) Schadde E., Schnitzbauer A.A., Tschuor C., Raptis D.A., Bechstein
W.O., Clavien P.A. Systematic Review and Meta-Analysis of Feasibility, Safety, and Efficacy of a Novel Procedure: Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. Ann Surg Oncol. 2015; 22(9): 3109-20
149) Schindl M.J., Redhead D.N., Fearon K.C. The value of residual liver
volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut. 2005;54:289–296.
150) Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ. The
value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut. 2005;54:289–296.
151) Schmidt SC, Hamann S, Langrehr JM, Höflich C, Mittler J, Jacob D, et
al. Preoperative high-dose steroid administration attenuates the surgical stress response following liver resection: results of a prospective randomized study. J Hepatobiliary Pancreat Surg. 2007;14:484–492.
152) Schnitzbauer A.A., Lang S.A., Goessmann H., Nadalin S., Baumgart J.,
Farkas S.A., Fichtner-Feigl S., Lorf T., Goralcyk A., Hörbelt R., Kroemer A., Loss M., Rümmele P., Scherer M.N., Padberg W., Königsrainer A., Lang H., Obed A., Schlitt H.J. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2­staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012; 255: 405–414
204
153) Schreckenbach T. et al. Posthepatectomy liver failure //Digestive
https://t.me/med1917
surgery. – 2012. – Vol. 29, №. 1. – P. 79-85.
154) Schreckenbach T., Liese J., Bechstein W.O., Moench C.
Posthepatectomy liver failure. Dig. Surg. 2012;29:79–85.
155) Sen S Davies NA Mookerkee RP Cheshire LM Hodges SJ.
Pathophysiological effects of albumin dialysis in acute on chronic liver failure: a randomized controlled study. Liver Transplantation . 2004;10:1109–1119.
156) Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischaemia–
reperfusion injury. Am J Surg. 2001;181:160–166.
157) Shaw BW, Jr., Martin DJ, Marquez JM, et al. Venous bypass in clinical
liver transplantation. Ann Surg 1984; 200 (4): 524–34.
158) Shontz R, Karuparthy V, Temple R, Brennan TJ. Prevalence and risk
factors predisposing to coagulopathy in patients receiving epidural analgesia for hepatic surgery. Reg Anesth Pain Med. 2009;34:308–311.
159) Siniscalchi A, Begliomini B, De Pietri L, Braglia V, Gazzi M, Masetti
M, et al. Increased prothrombin time and platelet counts in living donor right hepatectomy: implications for epidural anesthesia. Liver Transpl. 2004;10:1144–1149.
160) Slankamenac K, Breitenstein S, Held U, Beck-Schimmer B, Puhan MA,
Clavien PA. Development and validation of a prediction score for postoperative acute renal failure following liver resection. Ann Surg. 2009;250:720–728.
161) Stadlbauer V Krisper P Aigner R Haditsch B Jung A. Effect of
extracorporeal liver support by MARS and PROMETHEUS on serum cytokines in acute-on-chronic liver failure. Critical Care . 2006;10
162) Steen S. et al. 90% hepatectomy with a porto-hepatic shunt in a canine
model: a feasibility study //ILAR Journal. – 2012. – Vol. 53, №. 1. – P. 1-8.
205
163) Stockmann M., Lock J.F., Riecke B. Prediction of postoperative outcome
https://t.me/med1917
after hepatectomy with a new bedside test for maximal liver function capacity. Ann. Surg. 2009;250:119–125.
164) Sugimoto H. et al. Critical progressive small-graft injury caused by
intrasinusoidal pressure elevation following living donor liver transplantation //Transplantation proceedings. – Elsevier, 2004. – Vol. 36, №. 9. – P. 2750-2756.
165) Sun Z., Tang W., Sakamoto Y., Hasegawa K., Kokudo N. A systematic
review and meta-analysis of feasibility, safety and efficacy of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus two-stage hepatectomy (TSH). BioScience Trends. 2015; 9(5): 284­288
166) Sun Z., Tang W., Sakamoto Y., Hasegawa K., Kokudo N. A systematic
review and meta-analysis of feasibility, safety and efficacy of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus two-stage hepatectomy (TSH). BioScience Trends. 2015; 9(5): 284­288
167) Superina RA, Bambini D, Filler RM, et al. A new technique for resecting
“unresectable” liver tumors. J Pediatr Surg 2000; 35 (9): 1294–9.
168) Tapper EB, Tanaka KA, Sarmiento JM. Evaluation of haemostatic
factors in patients undergoing major hepatic resection and other major abdominal surgeries. Am Surg. 2011;77:1188–1193.
169) Taub R. Liver regeneration: from myth to mechanism. Nat. Rev. Mol.
Cell Biol. 2004;5:836–847.
170) Thasler WE, Bein T, Jauch KW. Perioperative effects of hepatic
resection surgery on haemodynamic, pulmonary fluid balance, and indocyanine green clearance. Langenbecks Arch Surg. 2002;387:271–275.
171) Theodoraki K, Arkadopoulos N, Fragulidis G, Voros D, Karapanos K,
Markatou M, et al. Transhepatic lactate gradient in relation to liver
206
ischaemia/reperfusion injury during major hepatectomies. Liver
https://t.me/med1917
Transpl. 2006;12:1825–1831.
172) Timchenko N.A. Aging and liver regeneration. Trends Endocrinol.
Metabol. 2009;20:171–176
173) Troisi R. et al. Effects of hemi‐portocaval shunts for inflow modulation
on the outcome of small‐for‐size grafts in living donor liver transplantation
//American journal of transplantation. – 2005. – Vol. 5, №. 6. – P. 1397-
1404.
174) Tu Y. L. et al. Impact of mesocaval shunt on safe minimal liver remnant:
Porcine model //World journal of gastroenterology: WJG. – 2013. – Vol. 19, №. 31. – P. 5076.
175) Tu Z., Bozorgzadeh A., Pierce R.H., Kurtis J., Crispe I.N., Orloff M.S.
TLR-dependent cross talk between human Kupffer cells and NK cells. J. Exp. Med. 2008;205:233–244.
176) Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, et
al. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB. 2012;14:506–513.
177) van de Kerkhove MP Hoekstra R Chamuleau RA van Gulik TM. Clinical
application of bioartificial liver support systems. Annals of Surgery . 2004;240:216–230.
178) van de Poll MC, Ligthart-Melis GC, Olde Damink SW, van Leeuwen
PA, Beets-Tan RG, Deutz NE, et al. The gut does not contribute to systemic ammonia release in humans without portosystemic shunting. Am J Physiol Gastrointest Liver Physiol. 2008;295:760–765.
179) van den Broek M.A., Olde Damink S.W., Dejong C.H. Liver failure after
partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int. 2008;28:767–780.
180) van Lienden K.P., van den Esschert J.W., de Graaf W., Bipat S., Lameris
J.S., van Gulik T.M., van Delden O.M. Portal Vein Embolization Before
207
Liver Resection: A Systematic Review. Cardiovasc Intervent Radiol. 2013;
https://t.me/med1917
36: 25–34
181) Varma V., Mehta N., Kumaran V., Nundy S. Indications and
contraindications of liver transplantation. Int J Hepatol. 2011
182) Vasavada B. B., Chen C. L., Zakaria M. Portal flow is the main predictor
of early graft dysfunction regardless of the GRWR status in living donor liver transplantation–A retrospective analysis of 134 patients //International Journal of Surgery. – 2014. – Vol. 12, №. 2. – P. 177-180.
183) Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen
predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065–2072. doi:
10.1200/JCO.2005.05.3074.
184) Wack K. Sinusoidal ultrastructure evaluated during the revascularization
of regenerating rat liver. Hepatology. 2001;33:363–378.
185) Wada H, Usui M, Sakuragawa N. Haemostatic abnormalities and liver
diseases. Semin Thromb Hemost. 2008;34:772–778.
186) Wang D. D. et al. Should temporary extracorporeal continuous portal
diversion replace meso/porta-caval shunts in “small-for-size” syndrome in porcine hepatectomy? //World journal of gastroenterology: WJG. – 2015. – Vol. 21, №. 3. – P. 888.
187) Wang X. Q. et al. Portal inflow preservation during portal diversion in
small-for-size syndrome //World journal of gastroenterology: WJG. – 2014. – Vol. 20, №. 4. – P. 1021.
188) Wang X. Q. et al. Portal inflow preservation during portal diversion in
small-for-size syndrome //World journal of gastroenterology: WJG. – 2014. – Vol. 20, №. 4. – P. 1021.
189) Weinberg L, Scurrah N, Gunning K, McNicol L. Postoperative changes
in prothrombin time following hepatic resection: implications for perioperative analgesia. Anaesth Intensive Care. 2006;34:438–443.
208
190) Wibmer A., Prusa A.M., Nolz R., Gruenberger T., Schindl M., Ba-
https://t.me/med1917
Ssalamah A. Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging. Radiology. 2013;269:777–786.
191) Yasui-Yamada S, Oiwa Y, Saito Y, et al. Impact of phase angle on
postoperative prognosis in patients with gastrointestinal and hepatobiliary– pancreatic cancer. Nutrition 2020;79-80:110891.
10.1016/j.nut.2020.110891.
192) Zheng Y., Yang H., He L. Reassessment of different criteria for
diagnosing post-hepatectomy liver failure: a single-center study of 1683 hepatectomy. Oncotarget. 2017;8:89269–89277.
193) Zipprich A., Kuss O., Rogowski S. Incorporating indocyanin green
clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut. 2010;59:963–968.